About Todd Lanman, MD

Todd Lanman, MD is Assistant Clinical Professor, Division of Neurosurgery at the University of California Los Angeles (UCLA) and a board certified neurosurgeon specializing in the treatment of spinal disorders.

Dr. Lanman graduated from Northwestern University School of Medicine, Chicago, IL as a member of the Alpha Omega Alpha Honor Medical Society. He completed a general surgery internship and neurological surgery residency at UCLA.

Dr. Lanman is a leading authority on minimal access spinal fusion techniques performed through micro incisions. New advancements in synthetic and absorbable polymers have enabled him to lead the field in cervical and lumbar fusion techniques using these new polymers. Techniques that utilize synthetic fusion products save the patient from undergoing bone harvesting procedures or implantation of human donor bone. Synthetic polymers mixed with bone morphogenic protein achieve a near 100% rate of fusion success. Many patients go home the same day of surgery or the day after.

Further, Dr. Lanman is one of the surgeons who participated in the initial study conducted by the Food and Drug Administration (FDA) involving the use of bone morphogenetic protein. Currently, he is participating in the FDA's clinical trials involving artificial discs.

Dr. Lanman is a member of many professional societies and organizations including the American Association of Neurological Surgeons, Congress of Neurological Surgeons, North American Spine Society, Fellow American College of Surgeons, and North American Skull Base Society.

Dr. Lanman has authored ten peer-reviewed journal articles, one book chapter, and lectures extensively teaching courses on the spinal fusion techniques he has developed.